HUP0200758A3 - Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them - Google Patents
Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0200758A3 HUP0200758A3 HU0200758A HUP0200758A HUP0200758A3 HU P0200758 A3 HUP0200758 A3 HU P0200758A3 HU 0200758 A HU0200758 A HU 0200758A HU P0200758 A HUP0200758 A HU P0200758A HU P0200758 A3 HUP0200758 A3 HU P0200758A3
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- polymorphic forms
- antidiabetic agent
- Prior art date
Links
- 239000003472 antidiabetic agent Substances 0.000 title 1
- 229940125708 antidiabetic agent Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/38—[b, e]-condensed with two six-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1999/000681 WO2000063191A1 (fr) | 1999-04-16 | 1999-04-16 | Nouvelles formes polymorphes d'un agent antidiabetique: procede de preparation et composition pharmaceutique contenant ces dernieres |
IN436MA1999 | 1999-04-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0200758A2 HUP0200758A2 (hu) | 2002-07-29 |
HUP0200758A3 true HUP0200758A3 (en) | 2003-07-28 |
Family
ID=26318745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0200758A HUP0200758A3 (en) | 1999-04-16 | 2000-04-17 | Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1171430A1 (fr) |
CN (1) | CN1351597A (fr) |
AU (1) | AU3831300A (fr) |
BG (1) | BG106022A (fr) |
BR (1) | BR0010683A (fr) |
CA (1) | CA2370401A1 (fr) |
CZ (1) | CZ20013711A3 (fr) |
EE (1) | EE200100529A (fr) |
HR (1) | HRP20010748A2 (fr) |
HU (1) | HUP0200758A3 (fr) |
IL (1) | IL145958A0 (fr) |
MX (1) | MXPA01010472A (fr) |
NO (1) | NO20015016L (fr) |
PL (1) | PL351492A1 (fr) |
RU (1) | RU2001130883A (fr) |
TR (1) | TR200103851T2 (fr) |
WO (1) | WO2000063192A1 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1263458B1 (fr) | 2000-03-08 | 2005-11-16 | Novo Nordisk A/S | Reduction du cholesterol seriques |
US6897199B2 (en) * | 2001-02-05 | 2005-05-24 | Dr. Reddy's Laboratories Ltd. | Pharmaceutically acceptable salts of phenoxazine and phenothiazine compounds |
JP4563675B2 (ja) | 2001-10-12 | 2010-10-13 | ハイ・ポイント・ファーマスーティカルズ、エルエルシー | 置換ピペリジン類、およびヒスタミンh3受容体関連疾患の治療のためのその使用 |
JP2005518391A (ja) | 2001-12-21 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | Gk活性化剤としてのアミド誘導体 |
AU2002255017B2 (en) * | 2002-04-19 | 2008-11-13 | Faes Farma, S.A. | Polymorph of 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-1-piperidinyl]ethyl]-alpha, alpha-dimethyl-benzeneacetic acid |
CA2744893A1 (fr) | 2002-06-27 | 2004-01-08 | Novo Nordisk A/S | Derives d'arylcarbonyle servant d'activateurs de glucokinase |
EP1625112B1 (fr) | 2003-05-14 | 2009-07-22 | High Point Pharmaceuticals, LLC | Nouveaux composes pour le traitement de l'obesite |
AU2004275928B2 (en) | 2003-09-30 | 2010-03-11 | Novo Nordisk A/S | Melanocortin receptor agonists |
EP2298337B1 (fr) | 2003-12-09 | 2017-02-22 | Novo Nordisk A/S | Régulation des préférences alimentaires en utilisant des agonistes du GLP-1 |
CA2551324C (fr) | 2004-01-06 | 2012-11-27 | Novo Nordisk A/S | Heteroaryl-urees et leur utilisation en tant qu'activateurs de glucokinase |
WO2005105785A2 (fr) | 2004-05-04 | 2005-11-10 | Novo Nordisk A/S | Nouveaux derives d'indole |
US8410047B2 (en) | 2004-06-11 | 2013-04-02 | Novo Nordisk A/S | Counteracting drug-induced obesity using GLP-1 agonists |
ES2391776T3 (es) | 2004-11-22 | 2012-11-29 | Novo Nordisk A/S | Formulaciones solubles, estables conteniendo insulina con una sal de protamina |
KR101066882B1 (ko) | 2004-12-03 | 2011-09-26 | 트랜스테크 파르마, 인크. | 헤테로방향족 글루코키나제 활성화제 |
ATE536344T1 (de) | 2005-07-04 | 2011-12-15 | High Point Pharmaceuticals Llc | Histamine h3 receptor antagonisten |
AU2006268589B2 (en) | 2005-07-14 | 2011-09-29 | Vtv Therapeutics Llc | Urea glucokinase activators |
EP1910317B1 (fr) | 2005-07-20 | 2013-07-03 | Eli Lilly And Company | Composés joints en position 1-amino |
PL1951658T3 (pl) | 2005-11-17 | 2013-02-28 | Lilly Co Eli | Antagoniści receptora glukagonu, preparatyka i zastosowania terapeutyczne |
ES2388681T3 (es) | 2006-03-28 | 2012-10-17 | High Point Pharmaceuticals, Llc | Benzotiazoles con actividad de los receptores de histamina H3 |
PL2079732T3 (pl) | 2006-05-29 | 2012-05-31 | High Point Pharmaceuticals Llc | 3-(1,3-benzodioksol-5-ylo)-6-(4-cyklopropylopiperazyn-1-ylo)-pirydazyna, jej sole i solwaty oraz jej zastosowanie jako antagonisty receptora histaminowego h3 |
EP2086951B1 (fr) | 2006-11-15 | 2011-12-21 | High Point Pharmaceuticals, LLC | Nouvelles 2-(2-hydroxyphényl) benzothiadiazines utilisées pour traiter l'obésité et le diabète |
WO2008059026A1 (fr) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Nouveaux 2-(2-hydroxyphényl)benzimidazoles utilisés pour traiter l'obésité et le diabète |
EP2099777B1 (fr) | 2007-01-11 | 2015-08-12 | Novo Nordisk A/S | Activateurs de l'urée glucokinase |
JP2010013472A (ja) * | 2009-09-09 | 2010-01-21 | Faes Farma Sa | 4−[2−[1−(2−エトキシエチル)−1H−ベンズイミダゾール−2−イル]−1−ピペリジニル]エチル]−α,α−ジメチルベンゼノ酢酸の多形体 |
BR112012021231A2 (pt) | 2010-02-26 | 2015-09-08 | Basf Plant Science Co Gmbh | método para acentuar o rendimento em plantas, planta, construto, uso de um construto, método para a produção de uma planta transgênica, partes coletáveis de uma planta, produtos derivados de uma planta, uso de um ácido nucleíco e método para a produção de um produto |
US20130012432A1 (en) | 2010-02-26 | 2013-01-10 | Novo Nordisk A/S | Peptides for Treatment of Obesity |
CA2792663A1 (fr) | 2010-03-26 | 2011-09-29 | Novo Nordisk A/S | Nouveaux analogues du glucagon |
WO2012104834A1 (fr) | 2011-02-03 | 2012-08-09 | Pharmedica Ltd. | Nouveaux films à dissolution orale pour administration d'insuline, pour traitement du diabète |
AU2012234276A1 (en) | 2011-03-28 | 2013-08-29 | Novo Nordisk A/S | Novel glucagon analogues |
AU2012311484B2 (en) | 2011-09-23 | 2017-04-13 | Novo Nordisk A/S | Novel glucagon analogues |
US20150004144A1 (en) | 2011-12-02 | 2015-01-01 | The General Hospital Corporation | Differentiation into brown adipocytes |
RS59124B1 (sr) | 2013-04-18 | 2019-09-30 | Novo Nordisk As | Stabilni, produženi koagonisti glp-1/glukagonskih receptora za medicinsku upotrebu |
EP3151852A1 (fr) | 2014-06-04 | 2017-04-12 | Novo Nordisk A/S | Co-agonistes de récepteur du glucagon/glp-1 à usage médical |
CN111032680A (zh) | 2017-03-15 | 2020-04-17 | 诺和诺德股份有限公司 | 能够与黑皮质素4受体结合的双环化合物 |
US20210221867A1 (en) | 2018-05-15 | 2021-07-22 | Novo Nordisk A/S | Compounds Capable of Binding to Melanocortin 4 Receptor |
WO2020053414A1 (fr) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Composés bicycliques aptes à se lier aux agonistes du récepteur de la mélanocortine 4 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5089514A (en) * | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
IN182496B (fr) * | 1996-02-20 | 1999-04-17 | Reddy Research Foundation | |
WO1997027191A1 (fr) * | 1996-06-19 | 1997-07-31 | Dr. Reddy's Research Foundation | Nouvelles formes polymorphes de la troglitazone ayant une activite anti-diabetique augmentee et procede pour leur preparation |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
FR2746099B1 (fr) * | 1996-03-13 | 1998-04-30 | Procede ameliore pour la preparation de derives de l'acide 3-(10-phenothiazyl)-propanoique ou 3-(10-phenoxazyl)-propanoique | |
WO1999019313A1 (fr) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Nouveaux composes tricycliques et leur utilisation en medecine, procede de preparation de ces derniers et compositions pharmaceutiques les contenant |
EP1051403A1 (fr) * | 1998-01-29 | 2000-11-15 | Dr. Reddy's Research Foundation | Nouveaux acides alcanoiques et leur utilisation en medecine, leur procede de preparation et compositions pharmaceutiques les contenant |
NZ504106A (en) * | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
-
2000
- 2000-04-17 CA CA002370401A patent/CA2370401A1/fr not_active Abandoned
- 2000-04-17 MX MXPA01010472A patent/MXPA01010472A/es unknown
- 2000-04-17 CZ CZ20013711A patent/CZ20013711A3/cs unknown
- 2000-04-17 TR TR2001/03851T patent/TR200103851T2/xx unknown
- 2000-04-17 WO PCT/IB2000/000470 patent/WO2000063192A1/fr active Search and Examination
- 2000-04-17 EP EP00917222A patent/EP1171430A1/fr not_active Withdrawn
- 2000-04-17 HU HU0200758A patent/HUP0200758A3/hu unknown
- 2000-04-17 CN CN00807705A patent/CN1351597A/zh active Pending
- 2000-04-17 PL PL00351492A patent/PL351492A1/xx not_active Application Discontinuation
- 2000-04-17 IL IL14595800A patent/IL145958A0/xx unknown
- 2000-04-17 RU RU2001130883/04A patent/RU2001130883A/ru unknown
- 2000-04-17 AU AU38313/00A patent/AU3831300A/en not_active Abandoned
- 2000-04-17 EE EEP200100529A patent/EE200100529A/xx unknown
- 2000-04-17 BR BR0010683-6A patent/BR0010683A/pt not_active IP Right Cessation
-
2001
- 2001-10-15 NO NO20015016A patent/NO20015016L/no not_active Application Discontinuation
- 2001-10-15 HR HR20010748A patent/HRP20010748A2/hr not_active Application Discontinuation
- 2001-10-16 BG BG106022A patent/BG106022A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
BG106022A (bg) | 2002-04-30 |
IL145958A0 (en) | 2002-07-25 |
PL351492A1 (en) | 2003-04-22 |
NO20015016L (no) | 2001-12-11 |
EE200100529A (et) | 2002-12-16 |
CN1351597A (zh) | 2002-05-29 |
RU2001130883A (ru) | 2004-03-20 |
CA2370401A1 (fr) | 2000-10-26 |
CZ20013711A3 (cs) | 2002-07-17 |
NO20015016D0 (no) | 2001-10-15 |
TR200103851T2 (tr) | 2002-04-22 |
AU3831300A (en) | 2000-11-02 |
HRP20010748A2 (en) | 2003-02-28 |
EP1171430A1 (fr) | 2002-01-16 |
MXPA01010472A (es) | 2002-05-06 |
BR0010683A (pt) | 2003-07-01 |
HUP0200758A2 (hu) | 2002-07-29 |
WO2000063192A1 (fr) | 2000-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0200758A3 (en) | Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them | |
AU4465200A (en) | Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them | |
AU2953699A (en) | Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them | |
HUP0203559A3 (en) | Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them | |
HUP0203257A3 (en) | Polymorphic forms of atorvastatin calcium, process for their preparations and pharmaceutical compositions containing them | |
HUP0204245A3 (en) | Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
IL149618A0 (en) | Pharmaceutical compositions comprising thiazolidinedione and process for preparation thereof | |
HUP0203183A3 (en) | Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use | |
HUP0003844A3 (en) | Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0400998A3 (en) | Novel compounds of anti-inflammatory, immunomodulatory and anti-proliferatory effect, process for their preparation and pharmaceutical compositions containing them | |
PL355844A1 (en) | Novel pharmaceutical compositions of anti-tubrcular drugs and process for their preparation | |
HUP0105108A3 (en) | Amide compounds, process for their preparation and pharmaceutical compositions containing them | |
AP2001002183A0 (en) | Ethanolate of zithromycin process for manufacture and pharmaceutical compositions thereof | |
HUP0302519A3 (en) | Crystalline forms of atorvastatin, process for their preparation and pharmaceutical compositions containing them | |
HUP0100731A3 (en) | New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them | |
HUP0104762A3 (en) | Pharmaceutical moxifloxacin compositions and process for their preparation | |
HUP0200881A3 (en) | Renin inhibitors, process for preparation of the compounds, pharmaceutical compositions containing them and their use | |
HUP0105160A3 (en) | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them | |
HUP0202654A3 (en) | Pharmaceutical compositions of fibrinolytic agent and process for preparation thereof | |
HUP0200580A3 (en) | Polymorphic crystalline forms of celecoxib, process their preparation and pharmaceutical compositions containing them | |
HUP0204318A3 (en) | Torsemide polymorphic forms, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0003053A3 (en) | Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them | |
HUP0401163A3 (en) | L crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation and pharmaceutical compositions containing the crystalline forms | |
AP2001002355A0 (en) | Derivatives of purine their preparation process and pharmaceutical compositions containing them | |
EG22344A (en) | Process for preparing of novel pharmaceutical composition |